Skip to content
Recall Observatory FDA recall evidence

Device product

INOMAX DSIR Nitric Oxide delivery system, Model 10007, software version 3.1.0., delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and comprehensive alarm systems. The primary clinical settings are Neonatal Intensive Care Units (NICU) and to transport of neonates.

Z-0575-2015

October 17, 2014

Class II

Product summary

Firm
INO Therapeutics (dba Ikaria)
Event
Event 69635
Status
Terminated
Classification
Class II
Quantity
9
Official record key
device-enforcement:Z-0575-2015

Official wording

Reason: An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.

Code information: Serial Numbers: DS20080152, DS20090925, DS20101076, DS20101499, DS20110886, DS20110965, DS20120099, DS20120150, DS20120169.

Distribution pattern: US Distribution in states of: VA and PA only.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.